medigraphic.com
ISSN 0016-3813 (Print)

2012, Number 1

<< Back Next >>

Gac Med Mex 2012; 148 (1)

Tendencias de mortalidad por cáncer cervicouterino en las siete regiones socioeconómicas y en las 32 entidades federativas de México en los años 2000-2008

Sánchez-Barriga JJ

Language: Spanish
References: 31
Page: 42-51
PDF size: 102.49 Kb.


ABSTRACT

Objective: To determinate the trend of mortality from cervical cancer nationwide, by federative entities and socioeconomic regions during the years 2000-2008. Methods: The records of mortality associated to cervical cancer for the period 2000-2008 were obtained from the National Information System of the Secretariat of Health. This information is generated by the National Institute of Statistics Geography and Informatics through the death certificates issued all around the country. The codes of the international disease classification 10 that correspond to the basic cause of death from cervical cancer were identified. The rates of mortality nationwide, by federative entity and by socioeconomic region were calculated. Through Poisson regression analysis was compared mortality rates from cervical cancer of the socioeconomic regions and federative entities. The 7 socioeconomic regions were elaborated by the National Institute of Statistics, Geography and Informatics and include the 32 federative entities according to indicators that are related to well-being such as education, occupation, health, housing and employment. Results: The federative entities and socioeconomic region with the strongest association with mortality from cervical cancer in the period 2000-2008 were Colima (RR: 1.67, IC 95%: 1.11-2.25 for the year 2000; RR: 1.92, IC 95%: 1.29-2.85 for the year 2008); Veracruz (RR: 1.85, IC 95%: 1.51-2.27 for 2000; RR: 1.91, IC 95%: 1.55-2.35 for 2008); Yucatan (RR: 2.24, IC 95%: 1.74-2.88 for 2000; RR: 1.90, IC 95%: 1.44-2.49 for 2008); and region 1 (RR: 1.41, IC 95%: 1.23-1.6 for 2001; RR: 1.38, IC 95%: 1.2-1.58 for 2007). In this region for the year 2000 and 2008 the RR was not statistically significant. Conclusions: Mortality rates per 100,000 women standardized using the world population decreased from 13.3 to 8.6 in the period 2000-2008. The entities and region with the strongest force of association with mortality due to cervical cancer were Colima, Veracruz, Yucatan and region 1.


REFERENCES

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.

  2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72-81.

  3. Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Pineros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine. 2008;26 Suppl 11:L1-15.

  4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer- Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Disponible en: http://globocan.iarc.fr.

  5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.

  6. Gamarra CJ, Valente JG, Azevedo e Silva G. Magnitude of mortality from cervical cancer in the Brazilian Northeast and socioeconomic factors. Rev Panam Salud Pública. 2010;28:100-6.

  7. Lofters AK, Hwang SW, Moineddin R, Glazier RH. Cervical cancer screening among urban immigrants by region of origin: a populationbased cohort study. Prev Med. 2010;51:509-16.

  8. Chhabra S, Bhavani M, Mahajan N, Bawaskar R. Cervical cancer in Indian rural women: trends over two decades. J Obstet Gynaecol. 2010;30:725-8.

  9. Goddard M, Smith P. Equity of access to health care services: theory and evidence from the UK. Soc Sci Med. 2001;53:1149-62.

  10. Macgregor JE, Campbell MK, Mann EM, Swanson KY. Screening for cervical intraepithelial neoplasia in North East Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ. 1994;308:1407-11.

  11. Gorey KM, Holowaty EJ, Fehringer G, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health. 1997;87:1156-63.

  12. Couture MC, Nguyen CT, Alvarado BE, Velásquez LD, Zunzunegui MV. Inequalities in breast and cervical cancer screening among urban Mexican women. Prev Med. 2008;47:471-6.

  13. Bradley CJ, Given CW, Roberts C. Health care disparities and cervical cancer. Am J Public Health. 2004;94:2098-103.

  14. Demasio KA. The complexity of finding solutions to reducing racial/ ethnic disparities in health care outcomes. Commentary on “A community approach to addressing excess breast and cervical cancer mortality among women of African descent in Boston”. Public Health Rep. 2003;118:348.

  15. Secretaría de Salud. Sistema Nacional de Información en Salud. Mortalidad. Disponible en: http://www.salud.gob.mx/apps/htdocs/estadisticas/mortalidad/.

  16. World Health Organization. International Statistical Classification of Diseases and Problems related to health. Tenth review CIE10. Geneva: World Health Organization; 1995.

  17. Inskip H, Beral V, Fraser P, Haskey J. Methods for age-adjustment of rates. Stat Med. 1983;2:455-66.

  18. Ahmad OB, Boschi-Pinto C, López AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. In: Global programm on evidence for health policy discussion paper. Series 31. Geneva: WHO; 1999. p. 1-12.

  19. Consejo Nacional de Población. Proyecciones de población en México 2000-2050.

  20. Instituto Nacional de Estadística y Geografía. Regiones Socioeconómicas de México. Disponible en: http://sc.inegi.org.mx/niveles/datosnbi/reg_soc_mexico.pdf.

  21. Cameron AC, Trivedi PK. Regression analysis of count data. Cambridge: Cambridge University Press; 1998.

  22. Palacio-Mejía LS, Rangel-Gómez G, Hernández-Ávila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Pública Mex. 2003;45 Suppl 3:315-25.

  23. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Registros de cáncer: principios y métodos. Publicación científica No. 95. Lyon, Francia: Agencia Internacional de Investigación sobre el Cáncer (IARC); 1995.

  24. Hintze J. Number cruncher statistical systems. Kaysville, Utah: NCSS and PASS; 2001.

  25. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164:1017-25.

  26. Murillo R, Almonte M, Pereira A, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine. 2008;26 Suppl 11:L37-48.

  27. Pérez-Cruz E, Winkler JL, Velasco-Mondragón E, et al. Screening and follow-up for cervical cancer prevention in rural Mexico using visual inspection. Salud Pública Mex. 2005;47:39-48.

  28. Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Ávila M. Regional differences in breast and cervical cancer mortality in Mexico between 1979-2006. Salud Pública Mex. 2009;51 Suppl 2:208-19.

  29. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101:1051-7.

  30. United Nations. World population prospects. New York: UN; 1991.

  31. Silvi J. On the estimation of mortality rates for countries of the Americas. Epidemiol Bull. 2003;24:1-5.




2020     |     www.medigraphic.com